How much revenue does the women's health diagnostics market generate?

In 2027 the market for women's health diagnostics is worth approximately USD 25.08 billion.

What is the forecasted size of the women's health diagnostics industry?

Women's Health Diagnostics Market size stood at USD 23.7 billion in 2026 and is predicted to grow at a 6.93% CAGR from 2027 to 2036, exceeding USD 46.32 billion by 2036.

How is the shift toward preventive healthcare influencing demand in the women's health diagnostics market?

Greater awareness and adherence to routine screening are making diagnostic utilization more preventive and consistent, prompting providers to invest in women-centered screening programs and integrated testing capabilities to manage steady patient demand.

Why are healthcare infrastructure improvements strategically important for women's health diagnostics adoption?

Expanded obstetric, gynecology, and diagnostic capabilities improve access to prenatal and reproductive testing, enabling more consistent clinician test ordering and allowing providers to offer broader, connected diagnostic pathways and follow-up services.

Why is cancer the largest application segment in the women's health diagnostics market?

Cancer accounted for 34.98% of the market in 2026, supported by the routine use of diagnostics for detection, monitoring, treatment planning, and follow-up care across established clinical pathways.

What is fueling the rapid growth of diagnostic laboratories in the women's health diagnostics market?

Diagnostic laboratories are the fastest-growing end-use segment as rising testing demand increases the need for efficient, scalable workflows capable of processing larger sample volumes outside hospital settings.

Why is North America the largest market for women’s health diagnostics?

North America holds 48.98% share supported by strong screening infrastructure, routine preventive care adoption, and integrated diagnostic pathways across oncology, gynecology, and reproductive health services.

How is Asia Pacific expanding in women’s health diagnostics?

Asia Pacific is projected at 8.36% CAGR driven by improved healthcare access, rising screening adoption, and expanding diagnostic services across hospitals and urban healthcare networks.

What are the prominent companies operating in the women's health diagnostics landscape?

Leading players in the women's health diagnostics market include F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (United States), Quest Diagnostics Incorporated (United States), Abbott Laboratories (United States), Becton, Dickinson and Company (United States), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Aspira Women’s Health Inc. (United States), Thermo Fisher Scientific Inc. (United States), Cardinal Health, Inc. (United States).